cbdMD (YCBD) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

External links

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Clean Ecosystem Environment Extraction Materials Nature Offset Oil Package Packaging Pandemic Raw Materials Wind Access African American Benefits Black Charitable Collective Bargaining Community Culture Customer Data Privacy Death Demographic Demographics Disability Diversity Diversity and Inclusion Employee Engagement Ethnic Gender Health and Safety Hire Hiring Human Capital Human Resources Incident Minority Privacy Product Safety Recall Reimbursement Retention Retirement Safety Satisfaction Skilled Skills Social Society Supplier Supply Chain Talent Union Violence Workforce Anti-corruption Assessment Assurance Attorneys General Audit Bonus Bribery Class Action Lawsuit Classified Claw Back Commitment Corporate Governance Corporate Purpose Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Investigation Leadership Litigant Litigation Long-term Majority Mission Oversee Oversight Plaintiff Pledging Purpose R&D Reputation Research and Development Responsibility Responsible Shareholder Proposals Special Meeting Strategy Sustainability Sustainable Targets Tax Tenure Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On February 16, 2023, cbdMD, Inc. held its 2023 annual meeting of shareholders where three proposals were voted upon. The proposals are described in detail in our definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on January 4, 2023. Of the 60,682,262 shares of our common stock outstanding and entitled to vote at the annual meeting, 29,962,710.69 shares (or 49%), constituting a quorum, were represented in person or by proxy at the 2022 annual meeting. At the meeting all the proposals were approved and the final vote on the proposals was recorded as follows:

Proposal 1:

The following directors were elected at the 2023 annual meeting of shareholders to hold office until the 2024 annual meeting of shareholders or their earlier resignation, removal or death:

Directors	“For”	“Against”	Broker Non-Votes
Bakari Sellers	26,273,192	3,119,747	569,772
William F. Raines, III	26,321,975	3,070,914	569,772
Scott G. Stephen	26,195,800	3,197,089	569,772
Dr. Sibyl Swift	26,887,466	2,505,473	569,772

Proposal 2:

The appointment of Cherry Bekaert LLP as our independent registered public accounting firm was ratified, based upon the following final tabulation of votes:

“For”		“Against”		“Abstain”
29,188,087		80,516		694,108

Proposal 3:

The amendment to our Articles of Incorporation, as amended, at the discretion of the board of directors, to effect a reverse stock split of our issued and outstanding shares of common stock, at a specific ratio, ranging from one-for-twenty (1:20) to one-for-fifty (1:50), at any time prior to the one-year anniversary date of the annual meeting, with the exact ratio to be determined by the board was approved, based upon the following final tabulation of votes:

“For”		“Against”		“Abstain”
26,518,758		3,437,896		6,057